Results 101 to 110 of about 813,784 (293)

Fetal Akinesia/Hypokinesia and Arthrogryposis of Neuromuscular Origin: Etiologic Groups, Genetics, and Phenotypic Spectrum

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To provide a comprehensive clinical and genetic characterization of individuals with arthrogryposis multiplex congenita (AMC), focusing on the distribution of genetic etiologies across the neuromuscular spectrum and comparing myogenic and neurogenic subtypes. Methods A total of 105 individuals with AMC were clinically and genetically
Florencia Pérez‐Vidarte   +13 more
wiley   +1 more source

Plasma microRNA Signature as Predictive Marker of Clinical Response to Therapy During Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Despite the availability of effective therapies for Multiple Sclerosis (MS), the unpredictable nature of disease progression and the variability in individual treatment outcomes call for reliable biomarkers. This pilot study aims to investigate the potential of plasma circulating microRNAs (miRNAs) as predictive biomarkers for ...
Fortunata Carbone   +19 more
wiley   +1 more source

Plasma BDNF in burnout-related depressive disorders: The mediating role of perceived social isolation and the biopsychological effect of a multimodal inpatient treatment

open access: yesJournal of Affective Disorders Reports
Background: The neurotrophic hypothesis of depression assumes that a reduced expression of BDNF may partially explain the development of depression, and that antidepressants increase BDNF levels and mood.
Roberto La Marca   +4 more
doaj  

Factors for Rituximab Refractoriness in AQP4‐IgG+ NMOSD: A Cohort Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neuromyelitis optica spectrum disorder (NMOSD) is a severe autoimmune condition of the central nervous system (CNS), often associated with aquaporin‐4 antibodies (AQP4‐IgG). Rituximab, a CD20+ B‐cell depleting monoclonal antibody, is widely used as first‐line therapy.
Mariano Marrodan   +8 more
wiley   +1 more source

Pyrroles as a Potential Biomarker for Oxidative Stress Disorders. [PDF]

open access: yesInt J Mol Sci, 2023
Lambert B, Semmler A, Beer C, Voisey J.
europepmc   +1 more source

The Diagnostic Value of Visual Evoked Potentials in Chronic Disorders of Consciousness

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective In chronic disorders of consciousness (DOCs), the distinction between vegetative state/unresponsive wakefulness syndrome (VS/UWS) and minimally conscious state (MCS) is as crucial as it is challenging. Evoked potentials (EPs) and event‐related potentials (ERPs) are helpful, but some limitations prevent their consistent use in the ...
Letizia Clementi   +14 more
wiley   +1 more source

Sleep disorders and posttraumatic stress in raped victims

open access: yesRevista de la Facultad de Medicina, 2012
Objective. To determine sleep disorders and posttraumatic stress symptoms in a group of raped female victims and to assess the causal influence by a survey of the association between exposed and unexposed groups and compare those events.
Franklin E. Escobar Córdoba   +2 more
doaj  

The effectiveness of web-based training for parents on post-traumatic stress disorder in children

open access: yesFrontiers in Psychology
IntroductionPost-traumatic stress disorder (PTSD) after an injury such as accidents is common in children and can affect their overall physical and mental functioning and quality of life.
Zakieh Omidvar Eshkalak   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy